Skip to navigation Skip to content

COVID-19 Studies Recruiting People with MS



The National MS Society is partnering with organizations and supporting research that seeks to understand the impacts of COVID-19 for people living with MS, both in those who have the infection and those who do not. Other studies may address the impact of COVID-19 vaccines in people with MS.

Learn more about COVID-19 and MS

Remote interview study: Healthcare during the pandemic

Sponsor:  University of Pittsburgh Medical Center 
Time to complete: 45-50 minutes
Researchers at University of Pittsburgh Medical Center are seeking volunteers for a research study seeking to describe the barriers and facilitators to engagement in healthcare for people with disabilities during the COVID-19 pandemic. You may qualify if you are: a person with a disability or a care provider for someone with a disability; and at least 18 years old. Participation in the study involves one or two interviews (approximately 45-60 minutes). Interviews will be on the phone or on Zoom video conference. Participants will be compensated.  For more information, contact study staff at 412-396-1511 or email 

MS Trial Alert: COVID-19 Vaccine Booster in People with MS

Sponsor: National Institute of Health’s National Institute of Allergy and Infectious Diseases.
Time to Complete: 13 months
 Investigators nationwide are recruiting 900 adults living with multiple sclerosis and other disorders, and up to 300 children with multiple sclerosis for a clinical trial to assess immune system responses to extra dose(s) of the authorized COVID-19 vaccines.
Learn more

Impact of the COVID-19 Pandemic on Fatigue

Sponsore: University of Michigan
Time to Complete: 30-40 minutes
All individuals with Multiple Sclerosis are invited to participate in a survey to help learn more about fatigue in MS and the impact of the COVID-19 pandemic on fatigue. Questions will include demographics, fatigue severity and how fatigue impacts your daily activities, questions about other MS symptoms, and questions about how the COVID-19 pandemic impacted fatigue.

Learn more

AI Healthcare Consultant for COVID Vaccine Concerns

Sponsor: University of Illinois at Urbana-Champaign
Time to Complete: Approximately 15-20 minutes 
Researchers are developing an artificial intelligence agent to understand and address the concerns about the COVID-19 vaccine among people with MS. Participants will be talking with the AI consultant for 15 - 20 minutes in an online meeting. Participants will be compensated for the participation time. Please fill out a brief screening form at the link below. A researcher will contact you to set up the meeting. Please contact for more information about the study. 
Link to screening form

COVID-19 Vaccines

Sponsor: iConquerMS
Time to Complete: 15-20 minutes
COVER-MS is a study that assesses the experiences of those diagnosed with MS who received the COVID-19 vaccines. If you have received the COVID-19 vaccine and are diagnosed with MS, visit the iConquerMS website to share your experience.

Learn More

Personal Experiences

Sponsor: iConquerMS™
Time to Complete: 15-20 minutes
iConquerMS is conducting this survey to learn more about how people affected by MS are dealing with the COVID-19 pandemic and what has been their personal experience with COVID-19.

Learn More

Submit Research Questions

Sponsor: iConquerMS™
Time to Complete: 1-2 minutes
iConquerMS is currently looking for research questions on the topic of COVID-19 and MS. What do you wish was better understood on this topic? Do you belong to a racial or ethnic minority group? They would especially like to hear from you. Communities of color have been affected more strongly by COVID-19 and often by MS as well.

Learn More


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.